Eva Tiensuu Janson

8.9k total citations · 2 hit papers
124 papers, 6.4k citations indexed

About

Eva Tiensuu Janson is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Eva Tiensuu Janson has authored 124 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Epidemiology, 78 papers in Oncology and 70 papers in Neurology. Recurrent topics in Eva Tiensuu Janson's work include Neuroendocrine Tumor Research Advances (102 papers), Neuroblastoma Research and Treatments (70 papers) and Lung Cancer Research Studies (66 papers). Eva Tiensuu Janson is often cited by papers focused on Neuroendocrine Tumor Research Advances (102 papers), Neuroblastoma Research and Treatments (70 papers) and Lung Cancer Research Studies (66 papers). Eva Tiensuu Janson collaborates with scholars based in Sweden, Norway and Denmark. Eva Tiensuu Janson's co-authors include Kjell Öberg, Barbro Eriksson, Mats Stridsberg, Staffan Welin, Britt Skogseid, Anders Sundin, Halfdan Sørbye, Per Hellman, Henning Grønbæk and Ulrich Knigge and has published in prestigious journals such as Science, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Eva Tiensuu Janson

122 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

2012 714 citations Halfdan Sørbye, Staffan Welin et al. profile →
European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for digestive neuroendocrine carcinoma

2023 75 citations Halfdan Sørbye, Enrique Grande et al. Journal of Neuroendocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Tiensuu Janson Sweden	42	5.0k	4.4k	3.5k	725	539	124	6.4k
Martin Anlauf Germany	35	3.0k 0.6×	2.7k 0.6×	2.0k 0.6×	480 0.7×	942 1.7×	92	4.3k
Hisato Igarashi Japan	30	1.6k 0.3×	1.8k 0.4×	799 0.2×	679 0.9×	872 1.6×	100	3.1k
Bo Wängberg Sweden	39	2.2k 0.5×	1.6k 0.4×	1.5k 0.4×	357 0.5×	1.1k 2.1×	124	3.9k
Maria Chiara Zatelli Italy	42	1.6k 0.3×	1.1k 0.3×	912 0.3×	1.2k 1.7×	943 1.7×	183	5.0k
Akihiro Sakurai Japan	23	1.3k 0.3×	826 0.2×	790 0.2×	621 0.9×	368 0.7×	122	2.8k
G Bussolati Italy	28	737 0.1×	949 0.2×	417 0.1×	543 0.7×	700 1.3×	94	3.0k
Cornelis J.M. Lips Netherlands	37	913 0.2×	960 0.2×	472 0.1×	1.8k 2.5×	1.0k 1.9×	96	4.5k
Gilbert J. Cote United States	46	1.0k 0.2×	1.5k 0.3×	542 0.2×	3.3k 4.6×	1.4k 2.7×	141	7.3k
Noriko Kimura Japan	29	685 0.1×	839 0.2×	647 0.2×	767 1.1×	2.0k 3.6×	188	4.6k
Anna Spada Italy	46	1.3k 0.3×	600 0.1×	514 0.1×	2.6k 3.7×	1.2k 2.2×	172	7.0k

Countries citing papers authored by Eva Tiensuu Janson

Since Specialization

Citations

This map shows the geographic impact of Eva Tiensuu Janson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Tiensuu Janson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Tiensuu Janson more than expected).

Fields of papers citing papers by Eva Tiensuu Janson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Tiensuu Janson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Tiensuu Janson. The network helps show where Eva Tiensuu Janson may publish in the future.

Co-authorship network of co-authors of Eva Tiensuu Janson

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Tiensuu Janson. A scholar is included among the top collaborators of Eva Tiensuu Janson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Tiensuu Janson. Eva Tiensuu Janson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sørbye, Halfdan, Geir Olav Hjortland, Lene Weber Vestermark, et al.. (2025). Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study. British Journal of Cancer. 133(3). 316–324. 8 indexed citations

Janson, Eva Tiensuu, P. Cédric M. P. Koolschijn, Lidewij Schipper, et al.. (2024). Dolphin CONTINUE: a multi-center randomized controlled trial to assess the effect of a nutritional intervention on brain development and long-term outcome in infants born before 30 weeks of gestation. BMC Pediatrics. 24(1). 384–384. 1 indexed citations

Fröss‐Baron, Katarzyna, Ulrike Garske‐Román, Anders Sundin, et al.. (2024). Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio ( dNLR ), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy : A retrospective, cohort study of 557 patients. Journal of Neuroendocrinology. 37(3). e13379–e13379. 1 indexed citations

Janson, Eva Tiensuu, et al.. (2024). Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸ Ga‐DOTATOC‐PET / CT in patients with small intestinal and pancreatic neuroendocrine tumours. Journal of Neuroendocrinology. 36(5). e13391–e13391. 4 indexed citations

Sørbye, Halfdan, Enrique Grande, Marianne Pavel, et al.. (2023). European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for digestive neuroendocrine carcinoma. Journal of Neuroendocrinology. 35(3). e13249–e13249. 75 indexed citations breakdown →

Tsoli, Marina, Göran Wallin, Eva Tiensuu Janson, et al.. (2022). Heterogeneity of Small Intestinal Neuroendocrine Tumors Metastasis: Biologic Patterns of a Series with Virchow’s Node Involvement. Cancers. 14(4). 913–913. 4 indexed citations

Pommergaard, Hans‐Christian, Halfdan Sørbye, Birgitte Federspiel, et al.. (2021). Surgery of the primary tumour in 201 patients with high‐grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine‐non‐neuroendocrine neoplasms. Journal of Neuroendocrinology. 33(5). e12967–e12967. 32 indexed citations

Grönberg, Malin, et al.. (2021). Adrenalectomy in ectopic Cushing’s syndrome: A retrospective cohort study from a tertiary care centre. Journal of Neuroendocrinology. 33(12). e13030–e13030. 5 indexed citations

Langer, Seppo W., Birgitte Federspiel, Geir Olav Hjortland, et al.. (2020). PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3. PLoS ONE. 15(12). e0243900–e0243900. 14 indexed citations

10.

Perren, Aurel, Jean‐Yves Scoazec, Laura H. Tang, et al.. (2020). A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations. Neuroendocrinology. 111(9). 883–894. 73 indexed citations

11.

Dam, Gitte, Henning Grønbæk, Halfdan Sørbye, et al.. (2019). Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors. Neuroendocrinology. 110(3-4). 217–224. 31 indexed citations

12.

Grönberg, Malin, Seppo W. Langer, Morten Ladekarl, et al.. (2018). Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3). Medical Oncology. 35(4). 47–47. 10 indexed citations

13.

Grönberg, Malin, Birgitte Federspiel, Jean‐Yves Scoazec, et al.. (2017). Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma. PLoS ONE. 12(11). e0187667–e0187667. 27 indexed citations

14.

Kaltsas, Gregory, Martyn Caplin, Philippa Davies, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors. Neuroendocrinology. 105(3). 245–254. 99 indexed citations

15.

Sørbye, Halfdan, Staffan Welin, Seppo W. Langer, et al.. (2013). Ki-67 Proliferative Index Predicts Response to Chemotherapy and Survival in 252 Patients with High-Grade Gastrointestinal Neuroendocrine Carcinoma (WHO G3). Pancreas. 42(2). 382–382. 2 indexed citations

16.

Cunningham, Janet L. & Eva Tiensuu Janson. (2011). The biological hallmarks of ileal carcinoids. European Journal of Clinical Investigation. 41(12). 1353–1360. 11 indexed citations

17.

Cunningham, Janet L., Eva Tiensuu Janson, Smriti Agarwal, Lars Grimelius, & Mats Stridsberg. (2007). Tachykinins in endocrine tumours and the carcinoid syndrome. 1 indexed citations

18.

Fjällskog, Marie-Louise, Ola Hessman, Barbro Eriksson, & Eva Tiensuu Janson. (2006). Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas. Acta Oncologica. 46(6). 741–746. 52 indexed citations

19.

Stridsberg, Mats, et al.. (2005). Expression of somatostatin receptor subtypes 1–5 in pancreatic islets of normoglycaemic and diabetic NOD mice. European Journal of Endocrinology. 153(3). 445–454. 8 indexed citations

20.

Janson, Eva Tiensuu, et al.. (1993). Combined Alpha- and Gamma-Interferon Therapy for Malignant Midgut Carcinoid Tumors a phase I-II trial. Acta Oncologica. 32(2). 231–233. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact